---
title: "AmoyDx released its 2024 annual performance, with a net profit attributable to the parent company of 255 million yuan, a year-on-year decrease of 2.53%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236760733.md"
description: "AmoyDx released its 2024 annual report, with operating revenue of 1.109 billion yuan, a year-on-year increase of 6.27%; net profit attributable to shareholders of the parent company was 255 million yuan, a year-on-year decrease of 2.53%; net profit excluding non-recurring gains and losses was 233 million yuan, a year-on-year decrease of 2.45%. The basic earnings per share were 0.64 yuan, and it plans to distribute a cash dividend of 3 yuan (tax included) for every 10 shares to all shareholders"
datetime: "2025-04-21T09:45:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236760733.md)
  - [en](https://longbridge.com/en/news/236760733.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236760733.md)
generator: "portal-rs"
---

# AmoyDx released its 2024 annual performance, with a net profit attributable to the parent company of 255 million yuan, a year-on-year decrease of 2.53%

According to the Zhitong Finance APP, AmoyDx (300685.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 1.109 billion yuan, a year-on-year increase of 6.27%. The net profit attributable to shareholders of the listed company was 255 million yuan, a year-on-year decrease of 2.53%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 233 million yuan, a year-on-year decrease of 2.45%. The basic earnings per share were 0.64 yuan. It is proposed to distribute a cash dividend of 3 yuan (including tax) for every 10 shares to all shareholders

### Related Stocks

- [300685.CN](https://longbridge.com/en/quote/300685.CN.md)

## Related News & Research

- [Church's Texas Chicken's China debut drew 2-hour lines — and $22 offers to wait in them](https://longbridge.com/en/news/297600833.md)
- [Khan demands Burnham block Heathrow expansion over net zero](https://longbridge.com/en/news/297836820.md)
- [EUR 10,000,000 3.5% Secondary Market Notes (ISIN XS1524568679)(AIV22) - Delisting](https://longbridge.com/en/news/297678136.md)
- [Cleo Diagnostics to Commence Analytical Validation of Pre-Surgical Ovarian Cancer Blood Test](https://longbridge.com/en/news/297848437.md)
- [Quirónsalud Zaragoza leads clinical trial in women with iron-deficiency anemia](https://longbridge.com/en/news/297808505.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**